ANTI-CANCER DRUG 润色咨询

ANTI-CANCER DRUGS

出版年份:1990 年文章数:1990 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=e9d3548, cover=https://img.medsci.cn/images/journal/cover/2021/AeB_202109271314157360.jpg, fullname=ANTI-CANCER DRUGS, abbr=ANTI-CANCER DRUG, pyear=1990, frequence=Monthly, articleNumbers=1990, citedSelf2015=2.1, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.46月, reviewFee=null, pageFee=3050.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0959-4973, greenSci=https://www.greensci.net/search?kw=0959-4973, scijournal=https://www.scijournal.org/impact-factor-of-ANTI-CANCER-DRUG.shtml, medsciHotlightString=null, medsciHotlightRealtime=11.049, medsciHotlight=14.903, medsciHotlight5year=12.4919, citescore=4.4, hIndex=93, impactFactor=2.3, orgnization=Lippincott Williams and Wilkins Ltd., orgnizationUrl=http://lwwonline.com, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=https://journals.lww.com/anti-cancerdrugs/pages/default.aspx, websiteHits=18843, guideForAuthor=null, guideForAuthorHits=43, submitWebsite=, submitWebsiteHits=11, content=Anti-Cancer Drugs is concerned with clinical and experimental effects of toxic and non-toxic cancer agents and is specifically directed toward breakthroughs in cancer treatment. Among the topics published are cytotoxic chemotherapy, hormonal or biological response modifiers such as interleukins, immunotherapy, drug design, adverse effects of drugs and drug resistance., totalCites=4578, brief=ANTI-CANCER DRUG杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的偏低级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #0000ff;">蓝</span>, medsciComment=虽然从国际上看,影响力一般。另外,大家关注整体偏低了一些,但是这是中国本土SCI期刊,取得这样成绩也是相当不错的,希望大家多关注支持!, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=e9d3548'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=17), ImpactFactorTagDto(id=137, tagName=药物, createdHits=5), ImpactFactorTagDto(id=1559, tagName=肿瘤学, createdHits=1), ImpactFactorTagDto(id=23056, tagName=drugs, createdHits=1), ImpactFactorTagDto(id=26031, tagName=THERAPY, createdHits=1), ImpactFactorTagDto(id=47483, tagName=cancer cell, createdHits=1), ImpactFactorTagDto(id=285, tagName=乳腺癌, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.25), GetImpactFactorCiteScoreListResponse(year=2017, citescore=1.94), GetImpactFactorCiteScoreListResponse(year=2018, citescore=1.98), GetImpactFactorCiteScoreListResponse(year=2019, citescore=3.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.4)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=11.627), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=13.478), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=16.682), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=11.301), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=11.049)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=104/232), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=157/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=184/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=139/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q3), GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q3)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0959-4973[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=ANTI-CANCER DRUGS[ta], article_number=244, article_number_cn=168, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
ANTI-CANCER DRUG/ANTI-CANCER DRUGS
ISSN
0959-4973
影响指数话题
预警等级
MedSci期刊指数
11.049 (MedSci实时期刊指数) | 12.4919 (5年期刊指数)
CiteScore值
4.4
h-index
93
h5-median
暂无数据
出版社/管理机构
杂志由 Lippincott Williams and Wilkins Ltd. 出版或管理
出版国家/地区
United States 美国
出版周期
Monthly
出版年份
1990
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
ONCOLOGY Q3
PHARMACOLOGY & PHARMACY Q3
中科院分区
大类:医学 4区
小类:医学 4 区